外科理论与实践 ›› 2020, Vol. 25 ›› Issue (05): 391-396.doi: 10.16139/j.1007-9610.2020.05.008
收稿日期:
2020-07-28
出版日期:
2020-09-25
发布日期:
2022-07-27
通讯作者:
朱孝成
E-mail:zhuxccf@163.com
ZHU Xiaocheng(), HOU Dongsheng
Received:
2020-07-28
Online:
2020-09-25
Published:
2022-07-27
中图分类号:
朱孝成, 侯栋升. 新型减重代谢手术方式:袖状胃切除加双通路[J]. 外科理论与实践, 2020, 25(05): 391-396.
ZHU Xiaocheng, HOU Dongsheng. New type of bariatric and metabolic procedure: sleeve gastrectomy with transit bipartition[J]. Journal of Surgery Concepts & Practice, 2020, 25(05): 391-396.
表1
SG-TB的手术方式及效果
参考文献 | n | 手术方式 | BMI | 糖化血红蛋白 | 糖尿病 缓解率(%) | 随访 时间(年) | |||
---|---|---|---|---|---|---|---|---|---|
术前 | 术后 | ||||||||
术前 | 术后 | ||||||||
Santoro等[ | 1 020 | Bougie=36Fr 胃-回肠吻合:吻合口直径3 cm, 距离回盲部260 cm 回肠-回肠吻合:距离回盲部80 cm | 42.2 | %EBMIL 74.0%±22.5% | - | - | 86 | 5 | |
Mahdy等[ | 551(多 中心) | 单吻合TB Bougie=36Fr 胃-回肠吻合:吻合口直径<3 cm, 距离回盲部250 cm | 43.2±12.5 | 31.1±9.7 | 8.1±3.6 | 5.3±2.6 | 83.9 | 1 | |
Mahdy等[ | 50 | 单吻合TB Bougie=36Fr 胃-回肠吻合:吻合口直径<3 cm, 距离回盲部250 cm | 48.7±7.6 | %EBMIL 90% | 9.9±2.7 | 5.1±0.8 | 100 | 1 | |
Topart等[ | 71 | Bougie=50Fr 胃-回肠吻合:吻合口直径3 cm, 距离回盲部250 cm 回肠-回肠吻合:距离回盲部100 cm | 51.6±5.0 | 29.2±4.5 | - | - | 80 | 2 | |
Yormaz等[ | 19 | 胃-回肠吻合:距离屈氏韧带150 cm 回肠-回肠吻合:距离回盲部80 cm | 36.6±2.1 | 25.5±2.2 | 9.0±1.2 | 6.0±1.5 | 82.9 | 1 | |
Emile等[ | 58(多 中心) | 单吻合TB Bougie=36Fr 胃-回肠吻合:吻合口直径<3 cm, 距离回盲部250 cm | 48.9±16.9 | 30.6±5.5 | - | - | 95.8 | 1 | |
Bilecik[ | 35 | 胃-回肠吻合:吻合口直径3~4 cm, 距离回盲部260 cm 回肠-回肠吻合:距离回盲部80 cm | 42.0±1.3 | 24.8±1.6 | 9.1±1.0 | 5.2±0.4 | 88.6 | 1 | |
Azevedo等[ | 10 | 胃-回肠吻合:吻合口直径3 cm, 距离回盲部250~260 cm 回肠-回肠吻合:距离回盲部120~130 cm | 33.4±2.6 | 30.9±2.5 | 9.3±2.1 | 5.5±1.1 | 90 | 2 | |
Karaca[ | 45 | Bougie=33Fr~45Fr 胃-回肠吻合:吻合口直径3.5~4.5 cm, 距离肠肠吻合150 cm 回肠-回肠吻合:距离回盲部80~120 cm | 38.0±8.7 | 24.8±2.4 | 9.1±1.3 | 5.6±0.6 | 88.8 | 1 | |
Rodrigues等[ | 9 | 胃-回肠吻合:距离回盲部260 cm 回肠-回肠吻合:距离回盲部80 cm | 31.2±2.2 | 减少22.8% | 10.6±0.6 | 6.7±0.1 (术后3个月) | 78 | 1 |
表2
SG-TB术后并发症
参考文献 | n | 随访时间(年) | 胆结石(n) | 吻合 口漏 (n) | 出血 (n) | 疝/梗阻(n) | 溃疡(n) | 腹泻 (>3次/d) | 贫血 (n) | 低蛋白 血症(n) | 反流(n) | 肺血 栓(n) | 其他(n) | 死亡 率 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Santoro等[ | 1 020 | 5 | 132 | 9 | 8 | 19(切口疝) 15(内疝或不完全性肠梗阻) 3(食管裂孔疝) | 1(吻合口溃疡) | - | - | - | 35% | 1 | 3(胃肠吻合口狭窄) 2(神经压迫) | 0.20% |
Mahdy等[ 单吻合TB | 551 | 1 | - | - | 1 | 1(肠梗阻) | 3(胃溃疡) | 15 | - | - | - | 1 | 32( 胆汁性呕吐) 2(梗阻性黄疸) 1(回肠穿孔) | 0 |
Mahdy等[ 单吻合TB | 50 | 1 | - | 1 | 1 | 1(完全性梗阻) | 1(吻合口溃疡) | 2 | - | 1(轻度) | - | 1 | - | 0 |
Topart等[ | 71 | 2 | - | - | - | 1.4%(内疝) | - | 7% | - | 6.5%(轻度) 1.4%(严重) | - | - | - | 0 |
Emile等[ 单吻合TB | 58 | 1 | - | - | 1 | 1(肠梗阻) | - | - | - | - | - | - | 2(肺炎) | 0 |
Bilecik[ | 35 | 1 | 1 | - | - | 1(不完全性肠梗阻) | - | - | - | - | - | - | 4(恶心呕吐) | 0 |
Azevedo等[ | 10 | 1 | 1 | - | - | - | - | - | 1 | 1 | - | - | - | 0 |
Karaca[ | 45 | 1 | 3 | - | - | - | - | - | - | - | 6 | - | 1(神经压迫) | 0 |
[1] | 王勇, 王存川, 朱晒红, 等. 中国肥胖及2型糖尿病外科治疗指南(2019版)[J]. 中国实用外科杂志, 2019, 39(4):301-306. |
[2] |
Santoro S, Castro LC, Velhote MC. Sleeve gastrectomy with transit bipartition: a potent intervention for metabo-lic syndrome and obesity[J]. Ann Surg, 2012, 256(1):104-110.
doi: 10.1097/SLA.0b013e31825370c0 pmid: 22609843 |
[3] | Lauti M, Kularatna M, Hill AG, et al. Weight regain following sleeve gastrectomy-a systematic review[J]. Obes Surg, 2016, 26(6):1326-1334. |
[4] |
Felsenreich DM, Kefurt R, Schermann M, et al. Reflux, sleeve dilation, and barrett′s esophagus after laparoscopic sleeve gastrectomy: long-term follow-up[J]. Obes Surg, 2017, 27(12):3092-3101.
doi: 10.1007/s11695-017-2748-9 pmid: 28593484 |
[5] |
Assalia A, Gagner M, Nedelcu M, et al. Gastroesophageal reflux and laparoscopic sleeve gastrectomy: results of the First International Consensus Conference[J]. Obes Surg, 2020, 30(10):3695-3705.
doi: 10.1007/s11695-020-04749-0 pmid: 32533520 |
[6] |
Capoccia D, Coccia F, Guarisco G, et al. Long-term metabolic effects of laparoscopic sleeve gastrectomy[J]. Obes Surg, 2018, 28(8):2289-2296.
doi: 10.1007/s11695-018-3153-8 pmid: 29497961 |
[7] |
Aminian A, Vidal J, Salminen P, et al. Late relapse of diabetes after bariatric surgery: not rare, but not a failure[J]. Diabetes Care, 2020, 43(3):534-540.
doi: 10.2337/dc19-1057 pmid: 31974105 |
[8] |
Peterli R, Wölnerhanssen BK, Peters T, et al. Effect of laparoscopic sleeve gastrectomy vs laparoscopic Roux-en-Y gastric bypass on weight loss in patients with morbid obesity: the SM-BOSS randomized clinical trial[J]. JAMA, 2018, 319(3):255-265.
doi: 10.1001/jama.2017.20897 pmid: 29340679 |
[9] |
Felsenreich DM, Langer FB, Kefurt R, et al. Weight loss, weight regain, and conversions to Roux-en-Y gastric bypass: 10-year results of laparoscopic sleeve gastrectomy[J]. Surg Obes Relat Dis, 2016, 12(9):1655-1662.
doi: S1550-7289(16)00066-6 pmid: 27317599 |
[10] |
van Wezenbeek MR, van Oudheusden TR, de Zoete JP, et al. Conversion to gastric bypass after either failed gastric band or failed sleeve gastrectomy[J]. Obes Surg, 2017, 27(1):83-89.
doi: 10.1007/s11695-016-2249-2 pmid: 27259684 |
[11] | Parmar CD, Mahawar KK, Boyle M, et al. Conversion of sleeve gastrectomy to Roux-en-Y gastric bypass is effective for gastro-oesophageal reflux disease but not for further weight loss[J]. Obes Surg, 2017, 27(7):1651-1658. |
[12] | Nevo N, Abu-Abeid S, Lahat G, et al. Converting a sleeve gastrectomy to a gastric bypass for weight loss fai-lure-is it worth it?[J]. Obes Surg, 2018, 28(2):364-368. |
[13] | Lager CJ, Esfandiari NH, Subauste AR, et al. Roux-en-Y gastric bypass vs. sleeve gastrectomy: balancing the risks of surgery with the benefits of weight loss[J]. Obes Surg, 2017, 27(1):154-161. |
[14] |
Scopinaro N. Thirty-five years of biliopancreatic diversion: notes on gastrointestinal 265 physiology to complete the published information useful for a better understan-ding and clinical use of the operation[J]. Obes Surg, 2012, 22(3):427-432.
doi: 10.1007/s11695-011-0554-3 pmid: 22187218 |
[15] | Topart PA, Becouarn G. Revision and reversal after bi-liopancreatic diversion for excessive side effects or ineffective weight loss: a review of the current literature on indications and procedures[J]. Surg Obes Relat Dis, 2015, 11(4):965-972. |
[16] |
Sánchez-Pernaute A, Rubio MÁ, Pérez Aguirre E, et al. Single-anastomosis duodenoileal bypass with sleeve gastrectomy: 270 metabolic improvement and weight loss in first 100 patients[J]. Surg Obes Relat Dis, 2013, 9(5):731-735.
doi: 10.1016/j.soard.2012.07.018 pmid: 22963820 |
[17] | Torres AJ. Laparoscopic single-anastomosis duodenal-jejunal bypass with sleeve gastrectomy (SADJB-SG): Surgical risk and long-term results[J]. Surg Obes Relat Dis, 2019, 15(2):243-244. |
[18] | Shoar S, Poliakin L, Rubenstein R, et al. Single anastomosis duodeno-ileal switch(SADIS): a systematic review of efficacy and safety[J]. Obes Surg, 2018, 28(1):104-113. |
[19] |
Santoro S, Mota FC, Aquino CG. Treating severe GERD and obesity with a sleeve gastrectomy with cardioplication and a transit bipartition[J]. Obes Surg, 2019, 29(4):1439-1441.
doi: 10.1007/s11695-019-03752-4 pmid: 30737760 |
[20] | Mahdy T, Emile SH, Madyan A, et al. Evaluation of the efficacy of single anastomosis sleeve ileal (SASI) bypass for patients with morbid obesity: a multicenter study[J]. Obes Surg, 2020, 30(3):837-845. |
[21] |
Mahdy T, Al Wahedi A, Schou C. Efficacy of single anastomosis sleeve ileal (SASI) bypass for type-2 diabetic morbid obese patients: gastric bipartition, a novel metabolic surgery procedure: a retrospective cohort study[J]. Int J Surg, 2016, 34:28-34.
doi: S1743-9191(16)30314-4 pmid: 27545956 |
[22] | Topart P, Becouarn G, Finel JB. Comparison of 2-year results of Roux-en-Y gastric bypass and transit bipartition with sleeve gastrectomy for superobesity[J]. Obes Surg, 2020, 30(9):3402-3407. |
[23] | Yormaz S, Yılmaz H, Ece I, et al. Laparoscopic ileal interposition with diverted sleeve gastrectomy versus laparoscopic transit bipartition with sleeve gastrectomy for better glycemic outcomes in T2DM patients[J]. Obes Surg, 2018, 28(1):77-86. |
[24] |
Emile SH, Madyan A, Mahdy T, et al. Single anastomosis sleeve ileal (SASI) bypass versus sleeve gastrectomy: a case-matched multicenter study[J]. Surg Endosc, 2020,doi: 10.1007/s00464-020-07430-w.
doi: 10.1007/s00464-020-07430-w URL |
[25] |
Bilecik T. Metabolic effects of sleeve gastrectomy with transit bipartition in obese females with type 2 diabetes mellitus: results after 1-year follow-up[J]. Obes Surg, 2019, 29(3):805-810.
doi: 10.1007/s11695-018-3603-3 pmid: 30448981 |
[26] | Azevedo FR, Santoro S, Correa-Giannella ML, et al. A prospective randomized controlled trial of the metabolic effects of sleeve gastrectomy with transit bipartition[J]. Obes Surg, 2018, 28(10):3012-3019. |
[27] |
Karaca FC. Effects of sleeve gastrectomy with transit bipartition on glycemic variables, lipid profile, liver enzymes, and nutritional status in type 2 diabetes mellitus patients[J]. Obes Surg, 2020, 30(4):1437-1445.
doi: 10.1007/s11695-019-04326-0 pmid: 31984455 |
[28] | Rodrigues MR, Santo MA, Favero GM, et al. Metabolic surgery and intestinal gene expression: digestive tract and diabetes evolution considerations[J]. World J Gastroenterol, 2015, 21(22):6990-6998. |
[29] | Topart P, Becouarn G, Finel JB. Is transit bipartition a better alternative to biliopancreatic diversion with duodenal switch for superobesity? comparison of the early results of both procedures[J]. Surg Obes Relat Dis, 2020, 16(4):497-502. |
[30] | Arterburn DE, Courcoulas AP. Bariatric surgery for obesity and metabolic conditions in adults[J]. BMJ, 2014, 349:g3961. |
[31] |
Widjaja J, Pan H, Dolo PR, et al. Short-term diabetes remission outcomes in patients with BMI ≤30 kg/m2 following sleeve gastrectomy[J]. Obes Surg, 2020, 30(1):18-22.
doi: 10.1007/s11695-019-04139-1 pmid: 31428971 |
[32] | O′Brien PE, Hindle A, Brennan L, et al. Long-term outcomes after bariatric surgery: a systematic review and meta-analysis of weight loss at 10 or more years for all bariatric procedures and a single-centre review of 20-year outcomes after adjustable gastric banding[J]. Obes Surg, 2019, 29(1):3-14. |
[33] |
Magouliotis DE, Tasiopoulou VS, Tzovaras G. One anastomosis gastric bypass versus Roux-en-Y gastric bypass for morbid obesity: an updated meta-analysis[J]. Obes Surg, 2019, 29(9):2721-2730.
doi: 10.1007/s11695-019-04005-0 pmid: 31172454 |
[1] | 张贵祥, 陈刚, 李正正, 陈亿, 杜潇, 程中. 减重代谢手术病人代谢危险因素与骨代谢血清标志物关系的研究[J]. 外科理论与实践, 2020, 25(06): 493-497. |
[2] | 花荣, 姚琪远. 减重代谢手术对肥胖型非酒精性脂肪肝治疗的意义[J]. 外科理论与实践, 2020, 25(05): 373-377. |
[3] | 闫文貌, 白日星. 减重代谢术后体重反弹的原因和防治措施[J]. 外科理论与实践, 2020, 25(05): 386-390. |
[4] | 张晨阳, 张弘玮, 韩晓东, 刘伟杰, 于浩泳, 张频. 腹腔镜Roux-en-Y胃旁路术与腹腔镜袖状胃切除术减重与改善代谢紊乱的比较研究[J]. 外科理论与实践, 2020, 25(05): 397-401. |
[5] | 廉东波, 刘晨, 闫巍, 杜德晓, 宫轲, 张能维. 减重代谢手术效果评价系统的应用[J]. 外科理论与实践, 2020, 25(05): 402-407. |
[6] | 刘瑞萍, 杨宁琍, 林士波, 管蔚, 梁辉. 三种减重代谢手术后妊娠结局及妊娠期并发症[J]. 外科理论与实践, 2020, 25(05): 408-412. |
[7] | 田沛荣, 刘洋, 边识博, 李梦伊, 张萌, 刘佳, 金岚, 张忠涛, 张鹏. 减重代谢手术对贫血相关指标影响的回顾性研究[J]. 外科理论与实践, 2020, 25(05): 413-416. |
[8] | 刘彦旸, 花荣, 许博, 沈奇伟, 黄先觉, 姚琪远. 新鲜冰冻尸体腹腔镜减重代谢手术的探索与实践[J]. 外科理论与实践, 2020, 25(05): 417-421. |
[9] | 吴立胜, 余建伟, 李煜, 代聪聪. 胃后壁优先分离四孔法腹腔镜袖状胃切除术(附122例报告)[J]. 外科理论与实践, 2020, 25(05): 422-425. |
[10] | 胡嵩浩, 董志勇, 王存川. 减重代谢手术的规范化与术式创新[J]. 外科理论与实践, 2020, 25(05): 361-363. |
[11] | 白洁, 陶凯雄. 达芬奇机器人在代谢手术领域的应用[J]. 外科理论与实践, 2018, 23(06): 491-494. |
[12] | 花荣, 陈浩, 丁锐, 许博, 沈奇伟, 姚琪远,. 袖状胃切除手术前后的胃食管反流病[J]. 外科理论与实践, 2017, 22(06): 493-498. |
[13] | 朱翠玲, 钱春花, 张怡, 高晶扬, 尤慧, 卢列盛, 董恒生, 周东雷, 曲伸,. 代谢性手术治疗重度肥胖伴非酒精性脂肪性肝病患者的疗效观察[J]. 内科理论与实践, 2017, 12(04): 256-261. |
[14] | 颜朝阳, 张志, 尉建安, 孙少华, 刘宇萌, 张忠涛, 孟化,. 腹腔镜袖状胃切除术对降低心血管代谢危险因素的近期疗效分析[J]. 外科理论与实践, 2015, 20(05): 395-398. |
阅读次数 | ||||||
全文 |
|
|||||
摘要 |
|
|||||